Exelixis, Inc.EXELNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P46
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q1 2026-0.52%
Q4 2025-8.30%
Q3 2025-1.69%
Q2 20252.13%
Q4 202420.15%
Q3 2024-15.31%
Q2 202415.82%
Q1 2024-13.28%
Q4 2023-4.85%
Q3 2023-2.53%
Q2 20237.86%
Q1 202310.19%
Q4 20223.71%
Q3 2022-6.33%
Q3 202219.34%
Q2 20223.58%
Q4 2021-2.21%
Q4 20213.11%
Q3 2021-3.77%
Q2 202124.15%
Q4 2020-6.52%
Q4 202047.49%
Q3 2020-5.00%
Q2 20208.47%
Q4 201913.19%
Q3 2019-12.84%
Q2 2019-2.20%
Q1 201914.82%
Q4 20188.85%
Q3 2018-7.20%
Q2 2018-1.50%
Q1 201813.83%
Q4 201721.29%
Q3 2017-6.38%
Q2 201718.88%
Q1 2017163.50%
Q4 2016-59.95%
Q3 2016-9.38%
Q3 20162.77%
Q2 2016103.33%